Flu Fog

Swine flu poses a real threat, but right now officials and an anxious public are short on good info.

The Next Cancer Bestseller?

Novartis has ambitious plans for its new kidney cancer drug.

Drug Sales To Shrink

This year, pharmaceuticals could see the worst sales growth of the past quarter century.

Is Avastin Living Up To The Hype?

Roche overpaid for Genentech. The question is by how much.

Merck, Schering Results Highlight Merger Need

Quarterly numbers show why Merck decided, after years of merger aversion, to buy Schering-Plough.